

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of erythrocyte differentiation (GO:0045647) | 6.67858622 |
| 2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.23802672 |
| 3 | locomotory exploration behavior (GO:0035641) | 4.92558343 |
| 4 | synaptic vesicle maturation (GO:0016188) | 4.60115443 |
| 5 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.48374805 |
| 6 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.30617554 |
| 7 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.28500036 |
| 8 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.08921847 |
| 9 | negative regulation of cell killing (GO:0031342) | 4.08921847 |
| 10 | sodium ion export (GO:0071436) | 3.86100071 |
| 11 | regulation of gamma-delta T cell activation (GO:0046643) | 3.84168492 |
| 12 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.79778469 |
| 13 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.78916961 |
| 14 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.73816615 |
| 15 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.73224020 |
| 16 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.66614146 |
| 17 | cellular potassium ion homeostasis (GO:0030007) | 3.61560348 |
| 18 | response to peptidoglycan (GO:0032494) | 3.58011457 |
| 19 | positive regulation by symbiont of host defense response (GO:0052509) | 3.57296227 |
| 20 | modulation by symbiont of host defense response (GO:0052031) | 3.57296227 |
| 21 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.57296227 |
| 22 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.57296227 |
| 23 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.57296227 |
| 24 | modulation by symbiont of host immune response (GO:0052553) | 3.57296227 |
| 25 | response to muramyl dipeptide (GO:0032495) | 3.55179399 |
| 26 | vocalization behavior (GO:0071625) | 3.54269427 |
| 27 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.50695069 |
| 28 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.50531578 |
| 29 | positive thymic T cell selection (GO:0045059) | 3.48317585 |
| 30 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.47508079 |
| 31 | regulation of synapse structural plasticity (GO:0051823) | 3.46705879 |
| 32 | synaptic vesicle exocytosis (GO:0016079) | 3.42777095 |
| 33 | megakaryocyte development (GO:0035855) | 3.41381648 |
| 34 | positive regulation of Rap GTPase activity (GO:0032854) | 3.39505769 |
| 35 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.39333394 |
| 36 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.39009198 |
| 37 | cellular extravasation (GO:0045123) | 3.36257325 |
| 38 | detection of other organism (GO:0098543) | 3.35274836 |
| 39 | positive regulation of B cell differentiation (GO:0045579) | 3.34959583 |
| 40 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.34348323 |
| 41 | neutrophil activation involved in immune response (GO:0002283) | 3.33289521 |
| 42 | regulation of ARF protein signal transduction (GO:0032012) | 3.32439691 |
| 43 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.31803540 |
| 44 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.30407689 |
| 45 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.27743023 |
| 46 | layer formation in cerebral cortex (GO:0021819) | 3.27225874 |
| 47 | detection of bacterium (GO:0016045) | 3.26822298 |
| 48 | neuronal action potential propagation (GO:0019227) | 3.26437265 |
| 49 | B cell receptor signaling pathway (GO:0050853) | 3.26271241 |
| 50 | potassium ion import (GO:0010107) | 3.21144708 |
| 51 | exploration behavior (GO:0035640) | 3.18386864 |
| 52 | activation of protein kinase A activity (GO:0034199) | 3.18067536 |
| 53 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.17941180 |
| 54 | dendritic spine morphogenesis (GO:0060997) | 3.16113303 |
| 55 | regulation of mast cell degranulation (GO:0043304) | 3.14677051 |
| 56 | oxygen transport (GO:0015671) | 3.08747082 |
| 57 | protein localization to synapse (GO:0035418) | 3.08284663 |
| 58 | glutamate secretion (GO:0014047) | 3.08012354 |
| 59 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.06967484 |
| 60 | regulation of leukocyte degranulation (GO:0043300) | 3.06658715 |
| 61 | neurotransmitter secretion (GO:0007269) | 3.06576658 |
| 62 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.05999658 |
| 63 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.04181250 |
| 64 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.02003845 |
| 65 | regulation of synaptic vesicle transport (GO:1902803) | 3.01919256 |
| 66 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.01097055 |
| 67 | thymic T cell selection (GO:0045061) | 3.00826457 |
| 68 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.99576681 |
| 69 | gas transport (GO:0015669) | 2.99218202 |
| 70 | positive regulation of granulocyte differentiation (GO:0030854) | 2.97390120 |
| 71 | prepulse inhibition (GO:0060134) | 2.97216817 |
| 72 | germinal center formation (GO:0002467) | 2.95830637 |
| 73 | macrophage activation involved in immune response (GO:0002281) | 2.94109580 |
| 74 | cell communication by electrical coupling (GO:0010644) | 2.94092238 |
| 75 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.93382893 |
| 76 | long-term memory (GO:0007616) | 2.92957194 |
| 77 | membrane depolarization during action potential (GO:0086010) | 2.92350521 |
| 78 | negative thymic T cell selection (GO:0045060) | 2.92138772 |
| 79 | regulation of ARF GTPase activity (GO:0032312) | 2.91389898 |
| 80 | definitive hemopoiesis (GO:0060216) | 2.90069454 |
| 81 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.89610878 |
| 82 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.88782587 |
| 83 | regulation of regulated secretory pathway (GO:1903305) | 2.88590423 |
| 84 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.87034926 |
| 85 | gamma-aminobutyric acid transport (GO:0015812) | 2.84654399 |
| 86 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.84637032 |
| 87 | creatine metabolic process (GO:0006600) | 2.84588436 |
| 88 | myeloid cell development (GO:0061515) | 2.83539862 |
| 89 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.83103072 |
| 90 | Peyers patch development (GO:0048541) | 2.83103072 |
| 91 | detection of external biotic stimulus (GO:0098581) | 2.82705722 |
| 92 | T cell selection (GO:0045058) | 2.82390502 |
| 93 | positive T cell selection (GO:0043368) | 2.80728997 |
| 94 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.80685283 |
| 95 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.80258018 |
| 96 | neuromuscular process controlling balance (GO:0050885) | 2.79624477 |
| 97 | glycine transport (GO:0015816) | 2.78147572 |
| 98 | regulation of Rap GTPase activity (GO:0032317) | 2.77924955 |
| 99 | regulation of erythrocyte differentiation (GO:0045646) | 2.77764474 |
| 100 | cellular sodium ion homeostasis (GO:0006883) | 2.74917332 |
| 101 | membrane hyperpolarization (GO:0060081) | 2.74730344 |
| 102 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.74427862 |
| 103 | striatum development (GO:0021756) | 2.74313884 |
| 104 | synaptic transmission, glutamatergic (GO:0035249) | 2.73934430 |
| 105 | erythrocyte development (GO:0048821) | 2.73583668 |
| 106 | regulation of postsynaptic membrane potential (GO:0060078) | 2.72517121 |
| 107 | establishment of nucleus localization (GO:0040023) | 2.72298449 |
| 108 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.71876210 |
| 109 | negative T cell selection (GO:0043383) | 2.71778068 |
| 110 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.71643364 |
| 111 | leukocyte aggregation (GO:0070486) | 2.71351824 |
| 112 | potassium ion homeostasis (GO:0055075) | 2.71044273 |
| 113 | response to interleukin-15 (GO:0070672) | 2.70957999 |
| 114 | L-amino acid import (GO:0043092) | 2.70400253 |
| 115 | regulation of histone H3-K27 methylation (GO:0061085) | 2.70037545 |
| 116 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.68551207 |
| 117 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.68080240 |
| 118 | regulation of macrophage cytokine production (GO:0010935) | 2.65722090 |
| 119 | neuron-neuron synaptic transmission (GO:0007270) | 2.65515532 |
| 120 | neuronal ion channel clustering (GO:0045161) | 2.65503079 |
| 121 | actin filament polymerization (GO:0030041) | 2.65000348 |
| 122 | glutamate receptor signaling pathway (GO:0007215) | 2.64171249 |
| 123 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.62641308 |
| 124 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.62201187 |
| 125 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.62201187 |
| 126 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 2.61888630 |
| 127 | retinal cone cell development (GO:0046549) | 2.61541237 |
| 128 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.60807920 |
| 129 | detection of molecule of bacterial origin (GO:0032490) | 2.60666522 |
| 130 | positive regulation of membrane potential (GO:0045838) | 2.59924403 |
| 131 | rhodopsin mediated signaling pathway (GO:0016056) | 2.58869964 |
| 132 | dendrite morphogenesis (GO:0048813) | 2.58565194 |
| 133 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.58287595 |
| 134 | regulation of granulocyte differentiation (GO:0030852) | 2.57651311 |
| 135 | natural killer cell differentiation (GO:0001779) | 2.57619792 |
| 136 | negative regulation of T cell mediated immunity (GO:0002710) | 2.57397254 |
| 137 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.56631899 |
| 138 | regulation of B cell differentiation (GO:0045577) | 2.56445956 |
| 139 | positive regulation of neurotransmitter transport (GO:0051590) | 2.55731587 |
| 140 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.53311156 |
| 141 | neutrophil activation (GO:0042119) | 2.53301947 |
| 142 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.52556441 |
| 143 | auditory behavior (GO:0031223) | 2.52344350 |
| 144 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.52079578 |
| 145 | membrane depolarization (GO:0051899) | 2.51593533 |
| 146 | response to auditory stimulus (GO:0010996) | 2.51197508 |
| 147 | proline transport (GO:0015824) | 2.49926809 |
| 148 | long-term synaptic potentiation (GO:0060291) | 2.49167952 |
| 149 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.48863554 |
| 150 | neurotransmitter transport (GO:0006836) | 2.47252731 |
| 151 | response to host immune response (GO:0052572) | 2.47179848 |
| 152 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.47179848 |
| 153 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.46843168 |
| 154 | synaptic vesicle endocytosis (GO:0048488) | 2.46701292 |
| 155 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.46620727 |
| 156 | detection of biotic stimulus (GO:0009595) | 2.46136946 |
| 157 | myeloid cell activation involved in immune response (GO:0002275) | 2.45666852 |
| 158 | leukocyte degranulation (GO:0043299) | 2.44703944 |
| 159 | positive regulation of protein dephosphorylation (GO:0035307) | 2.43994326 |
| 160 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.42883081 |
| 161 | regulation of synaptic plasticity (GO:0048167) | 2.41762857 |
| 162 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.41653691 |
| 163 | regulation of beta-amyloid formation (GO:1902003) | 2.41449681 |
| 164 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.41274411 |
| 165 | regulation of membrane repolarization (GO:0060306) | 2.40907186 |
| 166 | neuromuscular process controlling posture (GO:0050884) | 2.40689060 |
| 167 | response to host (GO:0075136) | 2.38685310 |
| 168 | response to host defenses (GO:0052200) | 2.38685310 |
| 169 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.38685310 |
| 170 | regulation of neurotransmitter secretion (GO:0046928) | 2.38572230 |
| 171 | mating behavior (GO:0007617) | 2.37700953 |
| 172 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.36606772 |
| 173 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.36599037 |
| 174 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.36015732 |
| 175 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.35847968 |
| 176 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.35554163 |
| 177 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.35294011 |
| 178 | nerve growth factor signaling pathway (GO:0038180) | 2.34349543 |
| 179 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.34298098 |
| 180 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.34172724 |
| 181 | transmission of nerve impulse (GO:0019226) | 2.33710591 |
| 182 | innervation (GO:0060384) | 2.33452324 |
| 183 | signal complex assembly (GO:0007172) | 2.33027796 |
| 184 | regulation of platelet aggregation (GO:0090330) | 2.32658139 |
| 185 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.32621174 |
| 186 | positive regulation of mast cell activation (GO:0033005) | 2.32276606 |
| 187 | chemosensory behavior (GO:0007635) | 2.32126210 |
| 188 | cerebellar granule cell differentiation (GO:0021707) | 2.31868512 |
| 189 | macrophage activation (GO:0042116) | 2.31773184 |
| 190 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.31240794 |
| 191 | regulation of mast cell activation (GO:0033003) | 2.31231464 |
| 192 | * mannose metabolic process (GO:0006013) | 2.30116132 |
| 193 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.30048897 |
| 194 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.29623921 |
| 195 | membrane repolarization (GO:0086009) | 2.29191242 |
| 196 | dopamine receptor signaling pathway (GO:0007212) | 2.28943660 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.92778519 |
| 2 | * VDR_21846776_ChIP-Seq_THP-1_Human | 3.08519912 |
| 3 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.92334117 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.85787336 |
| 5 | MYC_22102868_ChIP-Seq_BL_Human | 2.84819549 |
| 6 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.80659537 |
| 7 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.61731686 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.53755179 |
| 9 | * GATA1_19941826_ChIP-Seq_K562_Human | 2.50182309 |
| 10 | GATA1_22025678_ChIP-Seq_K562_Human | 2.47247881 |
| 11 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.45653585 |
| 12 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.40949206 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.37440989 |
| 14 | * VDR_24763502_ChIP-Seq_THP-1_Human | 2.33773450 |
| 15 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.33716612 |
| 16 | SPI1_23127762_ChIP-Seq_K562_Human | 2.31144161 |
| 17 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.29558131 |
| 18 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.29558131 |
| 19 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.19693336 |
| 20 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.18452406 |
| 21 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.16841834 |
| 22 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 2.13407669 |
| 23 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.13197022 |
| 24 | MAF_26560356_Chip-Seq_TH1_Human | 2.11923089 |
| 25 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.07640803 |
| 26 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 2.05288123 |
| 27 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.03095937 |
| 28 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.02696128 |
| 29 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.99794439 |
| 30 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.96623587 |
| 31 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.93099302 |
| 32 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.92549633 |
| 33 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.89911241 |
| 34 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.88290197 |
| 35 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.87752457 |
| 36 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.87462558 |
| 37 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.85432781 |
| 38 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.85379841 |
| 39 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.85355141 |
| 40 | UTX_26944678_Chip-Seq_JUKART_Human | 1.83872769 |
| 41 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.83653957 |
| 42 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.81681348 |
| 43 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.80322368 |
| 44 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.77459160 |
| 45 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.77257102 |
| 46 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.76587780 |
| 47 | * MAF_26560356_Chip-Seq_TH2_Human | 1.73893007 |
| 48 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.71003908 |
| 49 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.68231784 |
| 50 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.67113618 |
| 51 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.66721076 |
| 52 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.65288378 |
| 53 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.63063852 |
| 54 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.58938012 |
| 55 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.58215378 |
| 56 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.54224423 |
| 57 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.54208226 |
| 58 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.53586889 |
| 59 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.51403197 |
| 60 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.50942259 |
| 61 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50047921 |
| 62 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.49492707 |
| 63 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.48972031 |
| 64 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.48808641 |
| 65 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.45826922 |
| 66 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.45809424 |
| 67 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.43177921 |
| 68 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.42822008 |
| 69 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.42796416 |
| 70 | P68_20966046_ChIP-Seq_HELA_Human | 1.42473573 |
| 71 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.41310728 |
| 72 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.40295720 |
| 73 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.37425482 |
| 74 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.35686878 |
| 75 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.35628861 |
| 76 | MYB_26560356_Chip-Seq_TH1_Human | 1.35226076 |
| 77 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.34901892 |
| 78 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.33666595 |
| 79 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.32009510 |
| 80 | MYB_26560356_Chip-Seq_TH2_Human | 1.31798310 |
| 81 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.30806607 |
| 82 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.30289920 |
| 83 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.29311164 |
| 84 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.29171337 |
| 85 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.28729871 |
| 86 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.27544386 |
| 87 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.27020820 |
| 88 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.26673012 |
| 89 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.26501283 |
| 90 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.24974740 |
| 91 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.24675525 |
| 92 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.24318557 |
| 93 | AR_19668381_ChIP-Seq_PC3_Human | 1.24257165 |
| 94 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.24191369 |
| 95 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.23630996 |
| 96 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.21873512 |
| 97 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.21098040 |
| 98 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.21050765 |
| 99 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.21038119 |
| 100 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.20528015 |
| 101 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.20443349 |
| 102 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.20056820 |
| 103 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.17827496 |
| 104 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.17480392 |
| 105 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.17110538 |
| 106 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.16957300 |
| 107 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16731219 |
| 108 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.15996219 |
| 109 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.15106384 |
| 110 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.14523914 |
| 111 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.14383159 |
| 112 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.14199227 |
| 113 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14056859 |
| 114 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.13810310 |
| 115 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.13525126 |
| 116 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.11490137 |
| 117 | TP53_16413492_ChIP-PET_HCT116_Human | 1.10467313 |
| 118 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.09165627 |
| 119 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.08456960 |
| 120 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.08173806 |
| 121 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.06719072 |
| 122 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.05583911 |
| 123 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.04795738 |
| 124 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.03803375 |
| 125 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.03376039 |
| 126 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.02415612 |
| 127 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.02005957 |
| 128 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.01541057 |
| 129 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.00660704 |
| 130 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.00178839 |
| 131 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.99597654 |
| 132 | * STAT3_23295773_ChIP-Seq_U87_Human | 0.99129171 |
| 133 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.98826017 |
| 134 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.98064247 |
| 135 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97579666 |
| 136 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.97338159 |
| 137 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.96375194 |
| 138 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.96284218 |
| 139 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.96095701 |
| 140 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.96071245 |
| 141 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95729671 |
| 142 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.94836477 |
| 143 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.94287602 |
| 144 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.94125664 |
| 145 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.93568939 |
| 146 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.93049976 |
| 147 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.92765274 |
| 148 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.92741280 |
| 149 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.92167890 |
| 150 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.91499504 |
| 151 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.91144232 |
| 152 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.91132513 |
| 153 | TCF4_23295773_ChIP-Seq_U87_Human | 0.90573063 |
| 154 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.90257214 |
| 155 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.89855443 |
| 156 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.89672055 |
| 157 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.88811267 |
| 158 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.88582516 |
| 159 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.88550703 |
| 160 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.87484762 |
| 161 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.87484762 |
| 162 | * CTCF_27219007_Chip-Seq_Bcells_Human | 0.87347352 |
| 163 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.87086112 |
| 164 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.86535498 |
| 165 | RXR_22108803_ChIP-Seq_LS180_Human | 0.86490088 |
| 166 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.86131220 |
| 167 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.85622507 |
| 168 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.85583774 |
| 169 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.84293766 |
| 170 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.84244591 |
| 171 | AR_25329375_ChIP-Seq_VCAP_Human | 0.84216506 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.27863950 |
| 2 | MP0003635_abnormal_synaptic_transmissio | 3.21194282 |
| 3 | MP0003436_decreased_susceptibility_to | 3.19955916 |
| 4 | MP0003303_peritoneal_inflammation | 3.17910981 |
| 5 | MP0005551_abnormal_eye_electrophysiolog | 2.98807768 |
| 6 | MP0002822_catalepsy | 2.95428125 |
| 7 | MP0005451_abnormal_body_composition | 2.87238577 |
| 8 | MP0000751_myopathy | 2.69766836 |
| 9 | MP0003656_abnormal_erythrocyte_physiolo | 2.69304156 |
| 10 | MP0003880_abnormal_central_pattern | 2.59313875 |
| 11 | MP0009046_muscle_twitch | 2.55012271 |
| 12 | MP0004270_analgesia | 2.52557114 |
| 13 | MP0009745_abnormal_behavioral_response | 2.51159800 |
| 14 | MP0005423_abnormal_somatic_nervous | 2.51055205 |
| 15 | MP0009278_abnormal_bone_marrow | 2.46522705 |
| 16 | MP0002064_seizures | 2.44605257 |
| 17 | MP0005464_abnormal_platelet_physiology | 2.43087871 |
| 18 | MP0003724_increased_susceptibility_to | 2.39195173 |
| 19 | MP0004145_abnormal_muscle_electrophysio | 2.36195937 |
| 20 | MP0002063_abnormal_learning/memory/cond | 2.36146062 |
| 21 | MP0001486_abnormal_startle_reflex | 2.20572163 |
| 22 | MP0005058_abnormal_lysosome_morphology | 2.18279782 |
| 23 | MP0002419_abnormal_innate_immunity | 2.18068994 |
| 24 | MP0008569_lethality_at_weaning | 2.17461618 |
| 25 | MP0001835_abnormal_antigen_presentation | 2.10660689 |
| 26 | MP0002272_abnormal_nervous_system | 2.08120087 |
| 27 | MP0009780_abnormal_chondrocyte_physiolo | 2.03839371 |
| 28 | MP0001545_abnormal_hematopoietic_system | 2.00638449 |
| 29 | MP0005397_hematopoietic_system_phenotyp | 2.00638449 |
| 30 | MP0002572_abnormal_emotion/affect_behav | 1.99162728 |
| 31 | MP0008260_abnormal_autophagy | 1.98611267 |
| 32 | MP0005025_abnormal_response_to | 1.97922598 |
| 33 | MP0004130_abnormal_muscle_cell | 1.97693895 |
| 34 | MP0002909_abnormal_adrenal_gland | 1.96867226 |
| 35 | MP0002837_dystrophic_cardiac_calcinosis | 1.91444758 |
| 36 | MP0000569_abnormal_digit_pigmentation | 1.88711497 |
| 37 | MP0005000_abnormal_immune_tolerance | 1.88104572 |
| 38 | MP0003300_gastrointestinal_ulcer | 1.88012899 |
| 39 | MP0003763_abnormal_thymus_physiology | 1.85994490 |
| 40 | MP0002396_abnormal_hematopoietic_system | 1.83784364 |
| 41 | MP0001800_abnormal_humoral_immune | 1.79892859 |
| 42 | MP0008961_abnormal_basal_metabolism | 1.79842890 |
| 43 | MP0001501_abnormal_sleep_pattern | 1.74476319 |
| 44 | MP0002090_abnormal_vision | 1.73797381 |
| 45 | MP0002420_abnormal_adaptive_immunity | 1.72975679 |
| 46 | MP0002398_abnormal_bone_marrow | 1.72235494 |
| 47 | MP0003191_abnormal_cellular_cholesterol | 1.71979092 |
| 48 | MP0003011_delayed_dark_adaptation | 1.69473423 |
| 49 | MP0001819_abnormal_immune_cell | 1.69244508 |
| 50 | MP0000685_abnormal_immune_system | 1.68595097 |
| 51 | MP0004147_increased_porphyrin_level | 1.68146600 |
| 52 | MP0002723_abnormal_immune_serum | 1.67609198 |
| 53 | MP0001790_abnormal_immune_system | 1.67294023 |
| 54 | MP0005387_immune_system_phenotype | 1.67294023 |
| 55 | MP0005253_abnormal_eye_physiology | 1.66841359 |
| 56 | MP0004036_abnormal_muscle_relaxation | 1.65349810 |
| 57 | MP0004885_abnormal_endolymph | 1.62798879 |
| 58 | MP0001968_abnormal_touch/_nociception | 1.61473179 |
| 59 | MP0003690_abnormal_glial_cell | 1.56726081 |
| 60 | MP0003045_fibrosis | 1.56494145 |
| 61 | MP0004233_abnormal_muscle_weight | 1.52893072 |
| 62 | MP0003646_muscle_fatigue | 1.49503371 |
| 63 | MP0006072_abnormal_retinal_apoptosis | 1.48703291 |
| 64 | MP0003828_pulmonary_edema | 1.47495409 |
| 65 | MP0002734_abnormal_mechanical_nocicepti | 1.46998593 |
| 66 | MP0002452_abnormal_antigen_presenting | 1.46876294 |
| 67 | MP0000749_muscle_degeneration | 1.46070032 |
| 68 | MP0004947_skin_inflammation | 1.43631250 |
| 69 | MP0002067_abnormal_sensory_capabilities | 1.43428081 |
| 70 | MP0000716_abnormal_immune_system | 1.39515472 |
| 71 | MP0004808_abnormal_hematopoietic_stem | 1.39208622 |
| 72 | MP0003329_amyloid_beta_deposits | 1.38933315 |
| 73 | MP0002229_neurodegeneration | 1.36239442 |
| 74 | MP0000747_muscle_weakness | 1.34739699 |
| 75 | MP0001440_abnormal_grooming_behavior | 1.34441062 |
| 76 | MP0000703_abnormal_thymus_morphology | 1.32226213 |
| 77 | MP0004924_abnormal_behavior | 1.32199323 |
| 78 | MP0005386_behavior/neurological_phenoty | 1.32199323 |
| 79 | MP0004087_abnormal_muscle_fiber | 1.31043035 |
| 80 | MP0005671_abnormal_response_to | 1.30769339 |
| 81 | MP0004084_abnormal_cardiac_muscle | 1.30676689 |
| 82 | MP0004381_abnormal_hair_follicle | 1.29717021 |
| 83 | MP0004858_abnormal_nervous_system | 1.28757506 |
| 84 | MP0005646_abnormal_pituitary_gland | 1.28742385 |
| 85 | MP0002722_abnormal_immune_system | 1.28685177 |
| 86 | MP0000013_abnormal_adipose_tissue | 1.28577954 |
| 87 | MP0002882_abnormal_neuron_morphology | 1.28058499 |
| 88 | MP0004811_abnormal_neuron_physiology | 1.27831449 |
| 89 | MP0003633_abnormal_nervous_system | 1.26987687 |
| 90 | MP0001851_eye_inflammation | 1.26717309 |
| 91 | MP0000015_abnormal_ear_pigmentation | 1.25524400 |
| 92 | MP0002132_abnormal_respiratory_system | 1.24836803 |
| 93 | MP0003879_abnormal_hair_cell | 1.24458247 |
| 94 | MP0001533_abnormal_skeleton_physiology | 1.23866823 |
| 95 | MP0002405_respiratory_system_inflammati | 1.23368574 |
| 96 | MP0009840_abnormal_foam_cell | 1.22084659 |
| 97 | MP0004215_abnormal_myocardial_fiber | 1.21939611 |
| 98 | MP0001502_abnormal_circadian_rhythm | 1.21854042 |
| 99 | MP0002429_abnormal_blood_cell | 1.21521108 |
| 100 | MP0005670_abnormal_white_adipose | 1.21059567 |
| 101 | MP0005620_abnormal_muscle_contractility | 1.20012911 |
| 102 | MP0000689_abnormal_spleen_morphology | 1.18603929 |
| 103 | MP0004510_myositis | 1.18226177 |
| 104 | MP0005076_abnormal_cell_differentiation | 1.18010981 |
| 105 | MP0002009_preneoplasia | 1.16519128 |
| 106 | MP0002557_abnormal_social/conspecific_i | 1.16377101 |
| 107 | MP0006082_CNS_inflammation | 1.14166809 |
| 108 | MP0000920_abnormal_myelination | 1.13021821 |
| 109 | MP0000759_abnormal_skeletal_muscle | 1.12519668 |
| 110 | MP0004085_abnormal_heartbeat | 1.11976555 |
| 111 | MP0005409_darkened_coat_color | 1.11916974 |
| 112 | MP0002971_abnormal_brown_adipose | 1.11610558 |
| 113 | MP0002184_abnormal_innervation | 1.10848579 |
| 114 | MP0009785_altered_susceptibility_to | 1.10063099 |
| 115 | MP0001984_abnormal_olfaction | 1.09878369 |
| 116 | MP0001970_abnormal_pain_threshold | 1.08806055 |
| 117 | MP0003866_abnormal_defecation | 1.07646610 |
| 118 | MP0000955_abnormal_spinal_cord | 1.07348973 |
| 119 | MP0003172_abnormal_lysosome_physiology | 1.06860171 |
| 120 | MP0010155_abnormal_intestine_physiology | 1.06763195 |
| 121 | MP0002066_abnormal_motor_capabilities/c | 1.05994811 |
| 122 | MP0002998_abnormal_bone_remodeling | 1.05614497 |
| 123 | MP0002106_abnormal_muscle_physiology | 1.05217592 |
| 124 | MP0003634_abnormal_glial_cell | 1.04761696 |
| 125 | MP0003075_altered_response_to | 1.03159859 |
| 126 | MP0003705_abnormal_hypodermis_morpholog | 1.03000812 |
| 127 | MP0005195_abnormal_posterior_eye | 1.01937711 |
| 128 | MP0003787_abnormal_imprinting | 1.00720083 |
| 129 | MP0000003_abnormal_adipose_tissue | 1.00309152 |
| 130 | MP0005623_abnormal_meninges_morphology | 0.99568731 |
| 131 | MP0005083_abnormal_biliary_tract | 0.99144198 |
| 132 | MP0000465_gastrointestinal_hemorrhage | 0.98766477 |
| 133 | MP0005375_adipose_tissue_phenotype | 0.98271465 |
| 134 | MP0005666_abnormal_adipose_tissue | 0.97164871 |
| 135 | MP0000604_amyloidosis | 0.96151890 |
| 136 | MP0002148_abnormal_hypersensitivity_rea | 0.95927479 |
| 137 | MP0002733_abnormal_thermal_nociception | 0.94795276 |
| 138 | MP0008874_decreased_physiological_sensi | 0.94283114 |
| 139 | MP0003631_nervous_system_phenotype | 0.94210680 |
| 140 | MP0002269_muscular_atrophy | 0.94137161 |
| 141 | MP0009333_abnormal_splenocyte_physiolog | 0.94001650 |
| 142 | MP0005369_muscle_phenotype | 0.93996351 |
| 143 | MP0001845_abnormal_inflammatory_respons | 0.93790301 |
| 144 | MP0005535_abnormal_body_temperature | 0.92921084 |
| 145 | MP0003183_abnormal_peptide_metabolism | 0.91961882 |
| 146 | MP0009115_abnormal_fat_cell | 0.90630732 |
| 147 | MP0003137_abnormal_impulse_conducting | 0.90040943 |
| 148 | MP0005330_cardiomyopathy | 0.89237171 |
| 149 | MP0004484_altered_response_of | 0.88884024 |
| 150 | MP0001299_abnormal_eye_distance/ | 0.88665413 |
| 151 | MP0001177_atelectasis | 0.87710145 |
| 152 | MP0001873_stomach_inflammation | 0.87356739 |
| 153 | MP0004185_abnormal_adipocyte_glucose | 0.87026213 |
| 154 | MP0000778_abnormal_nervous_system | 0.87012264 |
| 155 | MP0002108_abnormal_muscle_morphology | 0.86484583 |
| 156 | MP0002735_abnormal_chemical_nociception | 0.83622229 |
| 157 | MP0002736_abnormal_nociception_after | 0.81473751 |
| 158 | MP0010630_abnormal_cardiac_muscle | 0.80948353 |
| 159 | MP0003950_abnormal_plasma_membrane | 0.80940681 |
| 160 | MP0002166_altered_tumor_susceptibility | 0.80527563 |
| 161 | MP0004742_abnormal_vestibular_system | 0.80135871 |
| 162 | MP0008469_abnormal_protein_level | 0.79934568 |
| 163 | MP0002752_abnormal_somatic_nervous | 0.78366524 |
| 164 | MP0005166_decreased_susceptibility_to | 0.78024993 |
| 165 | MP0002972_abnormal_cardiac_muscle | 0.76694764 |
| 166 | MP0002152_abnormal_brain_morphology | 0.75156418 |
| 167 | MP0001986_abnormal_taste_sensitivity | 0.74723556 |
| 168 | MP0000858_altered_metastatic_potential | 0.73710339 |
| 169 | MP0005167_abnormal_blood-brain_barrier | 0.73438020 |
| 170 | MP0001324_abnormal_eye_pigmentation | 0.73048514 |
| 171 | MP0006138_congestive_heart_failure | 0.72110402 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Congenital stationary night blindness (HP:0007642) | 4.56819752 |
| 2 | Central scotoma (HP:0000603) | 4.29725179 |
| 3 | Focal motor seizures (HP:0011153) | 4.15796299 |
| 4 | Eczematoid dermatitis (HP:0000976) | 3.85230666 |
| 5 | Prolonged bleeding time (HP:0003010) | 3.81577325 |
| 6 | Myokymia (HP:0002411) | 3.79153459 |
| 7 | Bony spicule pigmentary retinopathy (HP:0007737) | 3.65624189 |
| 8 | Focal seizures (HP:0007359) | 3.62622858 |
| 9 | Exercise-induced myalgia (HP:0003738) | 3.48927144 |
| 10 | Visual hallucinations (HP:0002367) | 3.39791904 |
| 11 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.39189432 |
| 12 | Action tremor (HP:0002345) | 3.35049875 |
| 13 | Obstructive sleep apnea (HP:0002870) | 3.32089344 |
| 14 | Recurrent abscess formation (HP:0002722) | 3.31808917 |
| 15 | Scotoma (HP:0000575) | 3.28493709 |
| 16 | Dysmetric saccades (HP:0000641) | 3.16859771 |
| 17 | Reticulocytosis (HP:0001923) | 3.09647214 |
| 18 | Polycythemia (HP:0001901) | 3.07433063 |
| 19 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.05995445 |
| 20 | Recurrent bacterial skin infections (HP:0005406) | 3.04793055 |
| 21 | Abnormality of the fingertips (HP:0001211) | 3.02967321 |
| 22 | Abnormality of macular pigmentation (HP:0008002) | 2.98591582 |
| 23 | Obstructive lung disease (HP:0006536) | 2.95671775 |
| 24 | Chronic obstructive pulmonary disease (HP:0006510) | 2.95671775 |
| 25 | Abnormality of macrophages (HP:0004311) | 2.95539668 |
| 26 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.94226961 |
| 27 | Pigmentary retinal degeneration (HP:0001146) | 2.92429105 |
| 28 | Spontaneous hematomas (HP:0007420) | 2.86257772 |
| 29 | Progressive cerebellar ataxia (HP:0002073) | 2.82410463 |
| 30 | Difficulty running (HP:0009046) | 2.82324787 |
| 31 | Supranuclear gaze palsy (HP:0000605) | 2.81478922 |
| 32 | Myositis (HP:0100614) | 2.77378786 |
| 33 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.76403470 |
| 34 | Epistaxis (HP:0000421) | 2.75594443 |
| 35 | Dysdiadochokinesis (HP:0002075) | 2.75531811 |
| 36 | Increased IgE level (HP:0003212) | 2.73978386 |
| 37 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.73910416 |
| 38 | Hemiplegia (HP:0002301) | 2.70472955 |
| 39 | Dyschromatopsia (HP:0007641) | 2.69965863 |
| 40 | Cellulitis (HP:0100658) | 2.68393256 |
| 41 | Postural instability (HP:0002172) | 2.62601930 |
| 42 | Colitis (HP:0002583) | 2.61413625 |
| 43 | Recurrent fungal infections (HP:0002841) | 2.60897850 |
| 44 | Macroorchidism (HP:0000053) | 2.59749155 |
| 45 | Truncal ataxia (HP:0002078) | 2.58275015 |
| 46 | Febrile seizures (HP:0002373) | 2.57924818 |
| 47 | Epileptic encephalopathy (HP:0200134) | 2.55902506 |
| 48 | Depression (HP:0000716) | 2.52809185 |
| 49 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.50088040 |
| 50 | Genetic anticipation (HP:0003743) | 2.49263080 |
| 51 | Broad-based gait (HP:0002136) | 2.48944145 |
| 52 | Slow saccadic eye movements (HP:0000514) | 2.47028055 |
| 53 | Gastrointestinal inflammation (HP:0004386) | 2.46818432 |
| 54 | Gaze-evoked nystagmus (HP:0000640) | 2.46761449 |
| 55 | Impaired social interactions (HP:0000735) | 2.46510505 |
| 56 | Abnormal social behavior (HP:0012433) | 2.46510505 |
| 57 | Bundle branch block (HP:0011710) | 2.46464318 |
| 58 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.45709739 |
| 59 | Diplopia (HP:0000651) | 2.43288257 |
| 60 | Broad metatarsal (HP:0001783) | 2.42500794 |
| 61 | Prolonged QT interval (HP:0001657) | 2.42349036 |
| 62 | Gastrointestinal infarctions (HP:0005244) | 2.41788488 |
| 63 | Meningitis (HP:0001287) | 2.41105014 |
| 64 | Ankle clonus (HP:0011448) | 2.40534765 |
| 65 | Hypochromic microcytic anemia (HP:0004840) | 2.39759757 |
| 66 | Peripheral hypomyelination (HP:0007182) | 2.39452370 |
| 67 | Exercise-induced muscle cramps (HP:0003710) | 2.38636696 |
| 68 | Bowel incontinence (HP:0002607) | 2.38584733 |
| 69 | Cholecystitis (HP:0001082) | 2.38260125 |
| 70 | Abnormal gallbladder physiology (HP:0012438) | 2.38260125 |
| 71 | Chorioretinal atrophy (HP:0000533) | 2.38209849 |
| 72 | Cerebral aneurysm (HP:0004944) | 2.37807281 |
| 73 | Gingival bleeding (HP:0000225) | 2.37778868 |
| 74 | Orchitis (HP:0100796) | 2.36069378 |
| 75 | Poor eye contact (HP:0000817) | 2.35203450 |
| 76 | Inflammation of the large intestine (HP:0002037) | 2.34209788 |
| 77 | Hyperthyroidism (HP:0000836) | 2.31176880 |
| 78 | Truncus arteriosus (HP:0001660) | 2.30253869 |
| 79 | Hypochromic anemia (HP:0001931) | 2.29976858 |
| 80 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.29235499 |
| 81 | Abolished electroretinogram (ERG) (HP:0000550) | 2.28845425 |
| 82 | Poikilocytosis (HP:0004447) | 2.28569501 |
| 83 | Dysmetria (HP:0001310) | 2.28057143 |
| 84 | Absence seizures (HP:0002121) | 2.27942529 |
| 85 | Hyperacusis (HP:0010780) | 2.26744287 |
| 86 | Atonic seizures (HP:0010819) | 2.26681509 |
| 87 | Increased variability in muscle fiber diameter (HP:0003557) | 2.25531175 |
| 88 | Hyporeflexia of lower limbs (HP:0002600) | 2.24867888 |
| 89 | Papilledema (HP:0001085) | 2.24534047 |
| 90 | Gingivitis (HP:0000230) | 2.23709064 |
| 91 | Decreased central vision (HP:0007663) | 2.23629235 |
| 92 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.23332466 |
| 93 | Intention tremor (HP:0002080) | 2.23303392 |
| 94 | Generalized tonic-clonic seizures (HP:0002069) | 2.22374065 |
| 95 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.21291509 |
| 96 | Abnormality of the lower motor neuron (HP:0002366) | 2.20734622 |
| 97 | Abnormal large intestine physiology (HP:0012700) | 2.20497618 |
| 98 | Calf muscle hypertrophy (HP:0008981) | 2.18645913 |
| 99 | Lower limb amyotrophy (HP:0007210) | 2.18312215 |
| 100 | Chest pain (HP:0100749) | 2.17886707 |
| 101 | Optic neuritis (HP:0100653) | 2.16167094 |
| 102 | Retrobulbar optic neuritis (HP:0100654) | 2.16167094 |
| 103 | Ventricular fibrillation (HP:0001663) | 2.15107944 |
| 104 | Insomnia (HP:0100785) | 2.14163604 |
| 105 | Type 1 muscle fiber predominance (HP:0003803) | 2.13608900 |
| 106 | Recurrent skin infections (HP:0001581) | 2.12632106 |
| 107 | Impaired smooth pursuit (HP:0007772) | 2.11494846 |
| 108 | Pointed chin (HP:0000307) | 2.09744779 |
| 109 | Sudden death (HP:0001699) | 2.08281588 |
| 110 | Hypertensive crisis (HP:0100735) | 2.08044201 |
| 111 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.07307405 |
| 112 | Recurrent cutaneous fungal infections (HP:0011370) | 2.07307405 |
| 113 | Abnormality of the calf musculature (HP:0001430) | 2.07270937 |
| 114 | Urinary urgency (HP:0000012) | 2.05374631 |
| 115 | Cholelithiasis (HP:0001081) | 2.04415481 |
| 116 | Abnormal EKG (HP:0003115) | 2.03973558 |
| 117 | Onion bulb formation (HP:0003383) | 2.03296320 |
| 118 | Microcytic anemia (HP:0001935) | 2.02753992 |
| 119 | Purpura (HP:0000979) | 2.02537117 |
| 120 | Recurrent viral infections (HP:0004429) | 2.01098558 |
| 121 | Petechiae (HP:0000967) | 2.00304595 |
| 122 | Muscle fiber splitting (HP:0003555) | 1.99918948 |
| 123 | EMG: neuropathic changes (HP:0003445) | 1.99744819 |
| 124 | Ocular albinism (HP:0001107) | 1.98482327 |
| 125 | Upper limb amyotrophy (HP:0009129) | 1.98272057 |
| 126 | Distal upper limb amyotrophy (HP:0007149) | 1.98272057 |
| 127 | Dialeptic seizures (HP:0011146) | 1.97574416 |
| 128 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.97427674 |
| 129 | Anxiety (HP:0000739) | 1.96766775 |
| 130 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.96075128 |
| 131 | Impaired platelet aggregation (HP:0003540) | 1.94863666 |
| 132 | Abnormal platelet function (HP:0011869) | 1.94863666 |
| 133 | Scanning speech (HP:0002168) | 1.94823033 |
| 134 | Encephalitis (HP:0002383) | 1.94168353 |
| 135 | Stomatitis (HP:0010280) | 1.93474512 |
| 136 | Dysostosis multiplex (HP:0000943) | 1.92335489 |
| 137 | Elfin facies (HP:0004428) | 1.92014307 |
| 138 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.91261542 |
| 139 | Arterial thrombosis (HP:0004420) | 1.89705206 |
| 140 | Torticollis (HP:0000473) | 1.89166187 |
| 141 | Abnormal platelet volume (HP:0011876) | 1.89089406 |
| 142 | Pendular nystagmus (HP:0012043) | 1.88892648 |
| 143 | Osteomyelitis (HP:0002754) | 1.87919264 |
| 144 | Episodic fever (HP:0001954) | 1.87799047 |
| 145 | Annular pancreas (HP:0001734) | 1.87736017 |
| 146 | Atrial fibrillation (HP:0005110) | 1.87317893 |
| 147 | Mediastinal lymphadenopathy (HP:0100721) | 1.86031719 |
| 148 | Decreased motor nerve conduction velocity (HP:0003431) | 1.85037468 |
| 149 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.84893300 |
| 150 | Myotonia (HP:0002486) | 1.84771192 |
| 151 | Pulmonary embolism (HP:0002204) | 1.84310938 |
| 152 | Vasculitis (HP:0002633) | 1.84289229 |
| 153 | Abnormal hemoglobin (HP:0011902) | 1.84087303 |
| 154 | Panhypogammaglobulinemia (HP:0003139) | 1.83950480 |
| 155 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.83916895 |
| 156 | Subaortic stenosis (HP:0001682) | 1.83916895 |
| 157 | Choroideremia (HP:0001139) | 1.83897431 |
| 158 | Resting tremor (HP:0002322) | 1.83566024 |
| 159 | Hemorrhage of the eye (HP:0011885) | 1.83270581 |
| 160 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.83028835 |
| 161 | Neuronal loss in central nervous system (HP:0002529) | 1.83010350 |
| 162 | Type II diabetes mellitus (HP:0005978) | 1.82640626 |
| 163 | Macular degeneration (HP:0000608) | 1.82584243 |
| 164 | Foot dorsiflexor weakness (HP:0009027) | 1.82567059 |
| 165 | Granulocytopenia (HP:0001913) | 1.82464269 |
| 166 | Metaphyseal cupping (HP:0003021) | 1.81932315 |
| 167 | Fatigue (HP:0012378) | 1.81756303 |
| 168 | Primary atrial arrhythmia (HP:0001692) | 1.81102352 |
| 169 | Rapidly progressive (HP:0003678) | 1.80700076 |
| 170 | Attenuation of retinal blood vessels (HP:0007843) | 1.80266375 |
| 171 | Spastic gait (HP:0002064) | 1.79757109 |
| 172 | Increased serum ferritin (HP:0003281) | 1.78218813 |
| 173 | Easy fatigability (HP:0003388) | 1.78001418 |
| 174 | Distal lower limb amyotrophy (HP:0008944) | 1.77392041 |
| 175 | Menorrhagia (HP:0000132) | 1.77001115 |
| 176 | Abnormality of saccadic eye movements (HP:0000570) | 1.76316796 |
| 177 | Stereotypic behavior (HP:0000733) | 1.75822624 |
| 178 | Neoplasm of the heart (HP:0100544) | 1.75239954 |
| 179 | Lower limb muscle weakness (HP:0007340) | 1.73943329 |
| 180 | Asymmetric septal hypertrophy (HP:0001670) | 1.71905155 |
| 181 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.68724010 |
| 182 | Frequent falls (HP:0002359) | 1.68123464 |
| 183 | Hypoventilation (HP:0002791) | 1.67174662 |
| 184 | Abnormal eating behavior (HP:0100738) | 1.66423266 |
| 185 | Abnormality of binocular vision (HP:0011514) | 1.65069646 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 2.91968993 |
| 2 | NTRK3 | 2.91871430 |
| 3 | TRIB3 | 2.53047847 |
| 4 | PRKD3 | 2.50011245 |
| 5 | MAP2K3 | 2.46855986 |
| 6 | CAMK1G | 2.28418198 |
| 7 | ERN1 | 2.21400001 |
| 8 | MAP4K1 | 2.20121013 |
| 9 | MAP3K9 | 2.05491412 |
| 10 | SIK2 | 2.00526749 |
| 11 | MAP3K4 | 1.92735665 |
| 12 | CAMKK1 | 1.88256731 |
| 13 | RIPK1 | 1.85438369 |
| 14 | NTRK2 | 1.85255424 |
| 15 | PAK6 | 1.80226897 |
| 16 | TYK2 | 1.78118237 |
| 17 | STK38 | 1.71078829 |
| 18 | DAPK2 | 1.67553415 |
| 19 | CAMK1D | 1.67227492 |
| 20 | PHKG1 | 1.65614812 |
| 21 | PHKG2 | 1.65614812 |
| 22 | FES | 1.63886113 |
| 23 | NTRK1 | 1.60797047 |
| 24 | PRKCH | 1.57732470 |
| 25 | TYRO3 | 1.54840892 |
| 26 | ZAP70 | 1.53678414 |
| 27 | PKN2 | 1.53583307 |
| 28 | DMPK | 1.49712780 |
| 29 | SIK1 | 1.43762735 |
| 30 | RIPK4 | 1.41117415 |
| 31 | MINK1 | 1.41014002 |
| 32 | TTN | 1.40294100 |
| 33 | IRAK4 | 1.37086685 |
| 34 | BLK | 1.36526685 |
| 35 | ICK | 1.34477129 |
| 36 | BTK | 1.33587091 |
| 37 | MAP3K7 | 1.33090974 |
| 38 | CDK12 | 1.31776715 |
| 39 | KSR2 | 1.29620473 |
| 40 | SGK3 | 1.27829893 |
| 41 | WNK1 | 1.27178344 |
| 42 | MAP2K4 | 1.25121683 |
| 43 | LMTK2 | 1.21009341 |
| 44 | JAK2 | 1.21007900 |
| 45 | PINK1 | 1.20763000 |
| 46 | MAP3K11 | 1.20632253 |
| 47 | MARK1 | 1.18693009 |
| 48 | SYK | 1.18417333 |
| 49 | SMG1 | 1.17605038 |
| 50 | CDK5 | 1.14690259 |
| 51 | GRK6 | 1.09868114 |
| 52 | RET | 1.09217836 |
| 53 | RAF1 | 1.09165973 |
| 54 | MAP3K10 | 1.05817595 |
| 55 | EPHB1 | 1.04833586 |
| 56 | MARK2 | 1.03816833 |
| 57 | SGK2 | 1.02955737 |
| 58 | SGK223 | 1.02254648 |
| 59 | SGK494 | 1.02254648 |
| 60 | MARK3 | 1.00306403 |
| 61 | CSK | 1.00263488 |
| 62 | TNK2 | 0.99705241 |
| 63 | CAMK1 | 0.99124448 |
| 64 | PRPF4B | 0.99109855 |
| 65 | EEF2K | 0.98775030 |
| 66 | PDGFRA | 0.98298310 |
| 67 | TAOK1 | 0.97917337 |
| 68 | FGFR4 | 0.96504742 |
| 69 | MAP3K13 | 0.95503510 |
| 70 | KSR1 | 0.95135501 |
| 71 | PDK1 | 0.94846719 |
| 72 | STK11 | 0.94452262 |
| 73 | ALK | 0.93893554 |
| 74 | TAOK3 | 0.92279877 |
| 75 | ITK | 0.91562062 |
| 76 | MAP3K3 | 0.91298570 |
| 77 | JAK3 | 0.90994532 |
| 78 | TNIK | 0.90628905 |
| 79 | FGFR2 | 0.89527073 |
| 80 | BMPR2 | 0.88469487 |
| 81 | CAMKK2 | 0.88075232 |
| 82 | MAP3K6 | 0.87272698 |
| 83 | PDPK1 | 0.85871493 |
| 84 | MAP3K14 | 0.85793177 |
| 85 | IRAK2 | 0.84384624 |
| 86 | MAPK12 | 0.80788090 |
| 87 | SGK1 | 0.79452595 |
| 88 | CDC42BPA | 0.79041033 |
| 89 | TRPM7 | 0.76481752 |
| 90 | MAP2K7 | 0.76476494 |
| 91 | PRKD2 | 0.75797849 |
| 92 | MAP2K6 | 0.74750805 |
| 93 | JAK1 | 0.73826409 |
| 94 | CAMK4 | 0.73703134 |
| 95 | GRK1 | 0.72799790 |
| 96 | TAOK2 | 0.72633135 |
| 97 | TBK1 | 0.70614795 |
| 98 | PTK2B | 0.70515065 |
| 99 | PDGFRB | 0.70382901 |
| 100 | TEC | 0.69699377 |
| 101 | PNCK | 0.69217111 |
| 102 | PRKD1 | 0.69037422 |
| 103 | MAP3K2 | 0.68955301 |
| 104 | IRAK3 | 0.67780362 |
| 105 | UHMK1 | 0.64333253 |
| 106 | HIPK2 | 0.62720641 |
| 107 | RPS6KA3 | 0.62216421 |
| 108 | PTK6 | 0.62073130 |
| 109 | MAPK13 | 0.60996995 |
| 110 | OBSCN | 0.60915533 |
| 111 | MTOR | 0.60554790 |
| 112 | IRAK1 | 0.60371866 |
| 113 | FYN | 0.58808510 |
| 114 | BMX | 0.58571235 |
| 115 | LYN | 0.58269277 |
| 116 | DDR2 | 0.58178392 |
| 117 | MAPK11 | 0.56447925 |
| 118 | LCK | 0.54633210 |
| 119 | YES1 | 0.53013549 |
| 120 | PAK3 | 0.52870726 |
| 121 | PRKCG | 0.51880718 |
| 122 | ARAF | 0.51601456 |
| 123 | PRKAA1 | 0.50986781 |
| 124 | KIT | 0.50597174 |
| 125 | IKBKE | 0.49961850 |
| 126 | LRRK2 | 0.49255080 |
| 127 | HCK | 0.49222257 |
| 128 | MAPK10 | 0.48998338 |
| 129 | MAP3K1 | 0.48915685 |
| 130 | PRKAA2 | 0.48905951 |
| 131 | MAPK7 | 0.48288952 |
| 132 | MATK | 0.48089389 |
| 133 | RPS6KL1 | 0.47881572 |
| 134 | RPS6KC1 | 0.47881572 |
| 135 | FGFR3 | 0.46269686 |
| 136 | CAMK2A | 0.45317721 |
| 137 | MAP2K2 | 0.44862476 |
| 138 | DAPK1 | 0.44800660 |
| 139 | SIK3 | 0.44275500 |
| 140 | RPS6KA2 | 0.42836481 |
| 141 | PKN1 | 0.42080142 |
| 142 | PRKCZ | 0.41304998 |
| 143 | ROCK1 | 0.40133168 |
| 144 | ROCK2 | 0.39788528 |
| 145 | MAPK8 | 0.39089242 |
| 146 | PDK3 | 0.38247620 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phototransduction_Homo sapiens_hsa04744 | 3.25711094 |
| 2 | Olfactory transduction_Homo sapiens_hsa04740 | 2.28931806 |
| 3 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.18714024 |
| 4 | Circadian entrainment_Homo sapiens_hsa04713 | 2.09983807 |
| 5 | Nicotine addiction_Homo sapiens_hsa05033 | 2.03349249 |
| 6 | GABAergic synapse_Homo sapiens_hsa04727 | 2.00402178 |
| 7 | Morphine addiction_Homo sapiens_hsa05032 | 1.97638341 |
| 8 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.95298218 |
| 9 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.91602685 |
| 10 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.90464653 |
| 11 | Other glycan degradation_Homo sapiens_hsa00511 | 1.85303158 |
| 12 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.84437656 |
| 13 | Long-term potentiation_Homo sapiens_hsa04720 | 1.82572375 |
| 14 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.78229832 |
| 15 | Leishmaniasis_Homo sapiens_hsa05140 | 1.76491027 |
| 16 | Salivary secretion_Homo sapiens_hsa04970 | 1.74004380 |
| 17 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.65862942 |
| 18 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.64848516 |
| 19 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.64503710 |
| 20 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.61351758 |
| 21 | Renin secretion_Homo sapiens_hsa04924 | 1.60571810 |
| 22 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.57520341 |
| 23 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.56492079 |
| 24 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.56431230 |
| 25 | Insulin secretion_Homo sapiens_hsa04911 | 1.54792105 |
| 26 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.52009138 |
| 27 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.45936480 |
| 28 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.44540780 |
| 29 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.40536328 |
| 30 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.38399639 |
| 31 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.38111480 |
| 32 | Cocaine addiction_Homo sapiens_hsa05030 | 1.32043682 |
| 33 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.30252389 |
| 34 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.29862276 |
| 35 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.28038920 |
| 36 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.27081906 |
| 37 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.26141432 |
| 38 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.24508955 |
| 39 | Tuberculosis_Homo sapiens_hsa05152 | 1.21148479 |
| 40 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.21032852 |
| 41 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.19172065 |
| 42 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.17781059 |
| 43 | Glioma_Homo sapiens_hsa05214 | 1.13576058 |
| 44 | Long-term depression_Homo sapiens_hsa04730 | 1.12181808 |
| 45 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.08376560 |
| 46 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.06957421 |
| 47 | Taste transduction_Homo sapiens_hsa04742 | 1.03547862 |
| 48 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.01550317 |
| 49 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.99383993 |
| 50 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.99071774 |
| 51 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.98824807 |
| 52 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.97882485 |
| 53 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.97803396 |
| 54 | Measles_Homo sapiens_hsa05162 | 0.96763286 |
| 55 | Gap junction_Homo sapiens_hsa04540 | 0.96599571 |
| 56 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.96539457 |
| 57 | Malaria_Homo sapiens_hsa05144 | 0.96120980 |
| 58 | Influenza A_Homo sapiens_hsa05164 | 0.96096049 |
| 59 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.95098739 |
| 60 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.94167254 |
| 61 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.94089784 |
| 62 | Hepatitis B_Homo sapiens_hsa05161 | 0.93988748 |
| 63 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.92927073 |
| 64 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.92678669 |
| 65 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.92489773 |
| 66 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.91914214 |
| 67 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.90455914 |
| 68 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.89839620 |
| 69 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.88854744 |
| 70 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.88262921 |
| 71 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.88151570 |
| 72 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.85672588 |
| 73 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.85055134 |
| 74 | Prion diseases_Homo sapiens_hsa05020 | 0.84244932 |
| 75 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.83472796 |
| 76 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.81986269 |
| 77 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.81761955 |
| 78 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.81059932 |
| 79 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.80992712 |
| 80 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.79605651 |
| 81 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.79208763 |
| 82 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.79059151 |
| 83 | Hepatitis C_Homo sapiens_hsa05160 | 0.78279764 |
| 84 | Axon guidance_Homo sapiens_hsa04360 | 0.78263877 |
| 85 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.77106719 |
| 86 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.77001183 |
| 87 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.76630262 |
| 88 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.76496462 |
| 89 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.76434285 |
| 90 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.76156367 |
| 91 | Insulin resistance_Homo sapiens_hsa04931 | 0.75563304 |
| 92 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.75454494 |
| 93 | Melanogenesis_Homo sapiens_hsa04916 | 0.74621445 |
| 94 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.73287396 |
| 95 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.72870709 |
| 96 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.72212983 |
| 97 | Circadian rhythm_Homo sapiens_hsa04710 | 0.72176124 |
| 98 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.71544207 |
| 99 | Platelet activation_Homo sapiens_hsa04611 | 0.71087065 |
| 100 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.69223482 |
| 101 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.68174529 |
| 102 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.65346110 |
| 103 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.65171980 |
| 104 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.64622429 |
| 105 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.64193428 |
| 106 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.63855975 |
| 107 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.62132217 |
| 108 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.61879510 |
| 109 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.61731587 |
| 110 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.61329067 |
| 111 | Focal adhesion_Homo sapiens_hsa04510 | 0.61294405 |
| 112 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.59102872 |
| 113 | Apoptosis_Homo sapiens_hsa04210 | 0.58206602 |
| 114 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.56425479 |
| 115 | Bile secretion_Homo sapiens_hsa04976 | 0.56414089 |
| 116 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.55951064 |
| 117 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.55632694 |
| 118 | Endocytosis_Homo sapiens_hsa04144 | 0.55367386 |
| 119 | Colorectal cancer_Homo sapiens_hsa05210 | 0.55129917 |
| 120 | Lysine degradation_Homo sapiens_hsa00310 | 0.54947804 |
| 121 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.54758910 |
| 122 | Allograft rejection_Homo sapiens_hsa05330 | 0.54451945 |
| 123 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.53786695 |
| 124 | Endometrial cancer_Homo sapiens_hsa05213 | 0.53692887 |
| 125 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.52799976 |
| 126 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.49424473 |
| 127 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.48616012 |
| 128 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.48542009 |
| 129 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.47214496 |
| 130 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.44532600 |
| 131 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.43476043 |
| 132 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.42227609 |
| 133 | Amoebiasis_Homo sapiens_hsa05146 | 0.41507923 |
| 134 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.40090784 |
| 135 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.39252820 |
| 136 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.38628708 |
| 137 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.37726140 |

